Cipmolnu 200 Capsule
Marketer
Cipla Ltd
Salt Composition
Molnupiravir (200mg)
Overview Cipmolnu 200 Capsule
Molnupiravir 200mg capsules represent a pioneering oral antiviral therapy for managing mild to moderate COVID-19 in adult patients. Its mechanism involves inhibiting viral replication, consequently lowering viral burden and disease intensity. This medication received emergency authorization from Indian regulatory bodies on December 28, 2021. Molnupiravir 200mg is exclusively prescribed for adults experiencing mild to moderate COVID-19 symptoms and exhibiting a heightened risk of severe illness. Risk factors include advanced age (over 60), obesity, diabetes, and cardiovascular conditions. It's contraindicated for individuals requiring immediate hospitalization for COVID-19. The drug has also gained emergency use approval from the U.S. Food and Drug Administration (FDA) and the UK's Medicines and Healthcare products Regulatory Agency (MHRA). The oral course should not exceed five consecutive days. Treatment completion is crucial; discontinue only under medical supervision. Potential side effects, including nausea, diarrhea, headache, and dizziness, should be reported to a physician for appropriate management. Prior to commencing treatment, patients should disclose all pre-existing health conditions and concurrent medications to their healthcare provider. Use during pregnancy is discouraged, and pregnant or breastfeeding individuals must consult their doctor before use.
Uses of Cipmolnu 200 Capsule
Managing mild-to-moderate cases of COVID-19
Major Benefits of Cipmolnu 200 Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Cipmolnu 200 Capsules. These capsules can be taken with or without food, however, consistent timing is recommended.
Common Side effects of Cipmolnu 200 Capsule:
- Nausea
- Dizziness
- Diarrhea
How to use Cipmolnu 200 Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Cipmolnu 200 Capsules. These capsules can be ingested with or without food, however, consistent timing is recommended.
How Cipmolnu 200 Capsule works:
Cipmolnu 200 Capsules offer antiviral action by suppressing SARS-CoV-2 replication. This mechanism prevents further viral proliferation, thus reducing the overall viral burden within the patient.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of Cipmolnu 200 Capsule with alcohol is uncertain. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Cipmolnu 200 Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Use of Cipmolnu 200 Capsules while breastfeeding is contraindicated due to potential infant toxicity.
DrivingCONSULT YOUR DOCTOR
The effect of Cipmolnu 200 Capsule on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Cipmolnu 200 Capsules pose no safety concerns for patients with kidney impairment; no dosage modification is necessary.
LiverSAFE IF PRESCRIBED
Cipmolnu 200 Capsules may be administered to patients with hepatic impairment without modification of the prescribed dosage.
What if you forget to take Cipmolnu 200 Capsule :
Omiting a scheduled dose of Cipmolnu 200 Capsule necessitates contacting your physician.
Facts to Know About Cipmolnu 200 Capsule
| Label | Value |
|---|---|
| Chemical Type | Cytosine Bases |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Actions | Non-HIV antiviral medications |
3,018 People bought this recently